Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Independent Contractors Tapped As Medicare Coverage Appeals Arbitrators

This article was originally published in The Gray Sheet

Executive Summary

Qualified independent contractors would be used to review Medicare coverage appeals for medical technology under a provision of House Ways and Means/Health Subcommittee Chairman Bill Thomas' (R-Calif.) Medicare drug benefit bill (HR 4680).

You may also be interested in...



Lab Test Payment Language Added To Medicare Technology Access Bill

Diagnostic test manufacturers would be able to request administrative review and revision of adverse coding and payment policy determinations for products covered by Medicare, under legislation (HR 4395) introduced May 10 by Reps. Jim Ramstad (R-Minn.) and Karen Thurman (D-Fla.).

Rep. Thomas' Medicare Appeals Bill Could Cost $1-2 Bil. Over Five Years

Legislation designed to accelerate the process for appealing Medicare coverage decisions by the Health Care Financing Administration and its intermediaries could cost as much as $1-2 bil. over five years, according to Rep. Bill Thomas (R-Calif.), sponsor of the legislation and chairman of the House Ways and Means/Health Subcommittee.

Reps Ramstad, Thomas Medicare Coverage Bills Set Specific Deadlines

Legislation (HR 2338) introduced June 24 by Rep. Jim Ramstad (R-Minn.) proposes a 30-day deadline for Health Care Financing Administration officials to meet with a device sponsor to discuss Medicare coverage.

Related Content

UsernamePublicRestriction

Register

MT013520

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel